Harbin Pharmaceutical Group Co. Ltd. A | Balance Sheet
Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,765
2,334
1,820
4,636
3,511
2,048
Total Accounts Receivable
5,642
4,541
4,086
3,517
3,626
3,284
Inventories
3,322
3,343
2,227
1,749
1,731
1,685
Other Current Assets
419
327
210
158
205
186
Total Current Assets
11,148
10,546
8,343
10,059
9,073
7,204
Net Property, Plant & Equipment
4,536
4,898
4,604
4,175
3,723
3,374
Total Investments and Advances
50
37
66
33
82
394
Intangible Assets
444
455
438
433
484
550
Other Assets
45
46
42
54
49
44
Total Assets
16,455
16,243
13,766
15,053
13,699
11,901
ST Debt & Current Portion LT Debt
1,661
1,602
1,264
1,477
1,626
Accounts Payable
3,217
2,941
2,254
2,620
2,195
Income Tax Payable
186
108
95
117
26
Other Current Liabilities
1,928
2,100
1,981
1,856
1,796
Total Current Liabilities
6,993
6,751
5,594
6,070
5,643
Long-Term Debt
59
53
49
49
48
Provision for Risks & Charges
-
38
31
55
20
Deferred Taxes
232
260
273
297
288
Other Liabilities
3
3
3
3
3
Total Liabilities
7,057
6,846
5,677
6,176
5,714
Common Equity (Total)
8,150
8,238
7,053
7,852
7,052
Total Shareholders' Equity
8,150
8,238
7,053
7,852
7,052
Total Equity
8,773
8,770
7,483
8,298
7,482
Liabilities & Shareholders' Equity
16,455
16,243
13,766
15,053
13,699
Accumulated Minority Interest
623
532
430
446
430
Non-Equity Reserves
626
627
606
578
504
About Harbin Pharmaceutical Group Co.
View Profile
